ask="1.99"
ask_size="700"
average_daily_volume="45865"
bid="N/A"
bid_size="N/A"
book_value="0.69"
change="+0.00"
change_from_200_day_moving_average="-0.01"
change_from_50_day_moving_average="-0.06"
change_from_52_week_high="-2.01"
change_From_52_week_low="0.45"
change_in_percent="+0.00%"
close="1.67"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.24"
ebitda="-6.29M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.72"
high_52_weeks="3.68"
last_trade_date="3/3/2017"
last_trade_price="1.67"
last_trade_size="100"
last_trade_time="3:24pm"
low="1.65"
low_52_weeks="1.22"
market_capitalization="18.35M"
moving_average_200_day="1.68"
moving_average_50_day="1.73"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.68"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.47%"
percent_change_from_50_day_moving_average="-3.24%"
percent_change_from_52_week_high="-54.62%"
percent_change_from_52_week_low="+36.89%"
previous_close="1.67"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.44"
price_per_sales="5.21"
revenue="3.52M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="19984"
weeks_range_52="1.22 - 3.68"
